Uttarakhand Government issues notice to Patanjali over Coronil

▴ Uttarakhand Government issues notice to Patanjali over Coronil
Patanjali applied for Coronil as an immunity booster for cough and cold says Y S Rawat, Licensing officer

The Uttarakhand government is serving a notice to yoga guru Ramdev’s Patanjali Ayurved for launching a drug claiming to be a cure for coronavirus when it had only applied for a license to manufacture an immunity booster against cough and fever, an official said Wednesday.

The revelation from the state comes even as the AYUSH ministry at the Centre prepares to examine the herbal products company’s documents on research and the composition of the drug developed by it. Union minister Shripad Naik said Patanjali coming with the medicine was a "good initiative" but due process has to be followed. Hours after the launch of 'Coronil' on Tuesday, the Union AYUSH Ministry had asked the firm to provide the details, telling it to stop advertising it till the issue is examined. Naik said Patanjali Ayurved has submitted the documents.

"The reports which were sent to the ministry on Tuesday will be examined," he said.

"At a time when everybody is grappling for a cure for coronavirus, such an initiative is definitely good but then the due process has to be followed," the minister said.Apart from the notice from the Uttarakhand government, the Haridwar-based firm could also face litigation in Bihar. A complaint has been filed against it in a Muzaffarpur court over its claim.

Uttarakhand’s Ayurved department’s license officer YS Rawat said the notice is being issued to the firm to explain from where it got the permission to launch a "corona kit" as a cure for the virus.

"Patanjali Ayurved Ltd had the license only for manufacturing an immunity booster against cough and fever. There was nothing in their application related to the treatment of coronavirus," the official said.

"We did receive an application from Patanjali on June 10. The application was approved after examination by a panel on June 12 but the firm had the permission to manufacture only two or three drugs as immunity boosters against cough and fever, and not a drug for coronavirus," he added.

He said the notice will be sent to the firm under Rule 170 of the Drugs and Cosmetics Act, 1940, which makes it mandatory for companies to seek permission from the licensing authority before advertising a product in print or electronic media.

In Muzaffarpur, a complainant has approached the court seeking the registration of an FIR against Ramdev and company chairman Acharya Balkrishna, alleging that they put at risk the lives of lakhs of people by claiming to have developed a Covid-19 cure.

Chief Judicial Magistrate Mukesh Kumar posted the matter for hearing on June 30.

At the “Coronil” launch, the company had claimed that its medicine can cure the contagious disease within seven days.

It said “Coronil”, taken along with another product developed by it, had shown a 100% success rate in clinical trials on infected patients, except those on life support.

Ramdev said the medicines were developed by Patanjali Research Center, Haridwar in association with privately-owned National Institute of Medical Science, Jaipur.

Patanjali, however, is not the only herbal products company to have claimed coming up with a cure against the contagious disease.

The Advertising Standards Council of India (ASCI) has said it has found 50 campaigns by Ayurveda and homeopathic drug makers offering a cure for coronavirus in April alone and had flagged them to the Union government for action.

The advertisements violated the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) order dated April 1, prohibiting publicity and advertisement of Ayush-related claims, an ASCI statement said.

The self-regulatory body said the ministry had sought its help to alert it about such advertisements.

The body also made public the list of the 50 companies which were found to have advertised a COVID-19 cure or a product to prevent it.

There were no big brands in the list, and most of them seemed to be localized entities from various parts of the country.

( Source PTI )

Tags : #Patanjali #Ramdev #Coronil #AyushMinistry #ShripadNaik #Coronakit #UttarakhandGovernment

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024